Status:
UNKNOWN
SMART Brain Health in African-Americans
Lead Sponsor:
Howard University
Collaborating Sponsors:
Medical Home Development Group
Geneus Health
Conditions:
Opioid Use Disorder
Substance Use Disorders
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The investigators hypothesize that opioid use in African-Americans will be associated with hypodopaminergic alleles that alter the threshold for activating feelings of reward and pleasure within the d...
Detailed Description
Individuals seeking treatment for Opioid Use Disorder in the Washington DC metro area will be recruited to this Study, which consists of 1) early pre-disposition diagnosis using the Genetic Addiction ...
Eligibility Criteria
Inclusion
- Must be able to consent and understand questions being asked during surveys
- Must be willing to undergo pharmacogenetic testing
- Must be able to swallow tablets
Exclusion
- Clinical Diagnosis of Alzheimer's disease/Dementia
- Clinical Diagnosis of Schizophrenia
- Clinical Diagnosis of a terminal disorder
Key Trial Info
Start Date :
June 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2019
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03861832
Start Date
June 16 2018
End Date
August 30 2019
Last Update
March 4 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Howard University
Washington D.C., District of Columbia, United States, 20059
2
Medical Home Development Group
Washington D.C., District of Columbia, United States, 20059